UBS AM’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Buy
96,902
+1,704
+2% +$30.5K ﹤0.01% 2134
2025
Q4
$1.53M Sell
95,198
-7,902
-8% -$118K ﹤0.01% 1984
2025
Q3
$1.27M Sell
103,100
-62,545
-38% -$733K ﹤0.01% 1928
2025
Q2
$1.91M Buy
165,645
+52,732
+47% +$625K ﹤0.01% 2164
2025
Q1
$1.69M Buy
112,913
+8,177
+8% +$137K ﹤0.01% 2071
2024
Q4
$1.81M Sell
104,736
-14,707
-12% -$284K ﹤0.01% 2102
2024
Q3
$2.21M Buy
119,443
+133
+0.1% +$2.67K ﹤0.01% 1985
2024
Q2
$2.42M Buy
119,310
+33,339
+39% +$590K ﹤0.01% 1899
2024
Q1
$1.47M Buy
85,971
+14,600
+20% +$230K ﹤0.01% 1828
2023
Q4
$1.26M Buy
71,371
+700
+1% +$14.1K ﹤0.01% 1904
2023
Q3
$1.7M Buy
70,671
+11,234
+19% +$276K ﹤0.01% 1710
2023
Q2
$1.31M Hold
59,437
﹤0.01% 1876
2023
Q1
$1.31M Buy
59,437
+633
+1% +$14.8K ﹤0.01% 1876
2022
Q4
$1.19M Buy
58,804
+3,298
+6% +$63.9K ﹤0.01% 1773
2022
Q3
$748K Buy
55,506
+1,505
+3% +$25.4K ﹤0.01% 2136
2022
Q2
$1.07M Sell
54,001
-6,794
-11% -$180K ﹤0.01% 1918
2022
Q1
$1.92M Sell
60,795
-811
-1% -$22.7K ﹤0.01% 1813
2021
Q4
$1.37M Buy
61,606
+6,011
+11% +$157K ﹤0.01% 2045
2021
Q3
$1.54M Sell
55,595
-2,339
-4% -$71.2K ﹤0.01% 1949
2021
Q2
$2.26M Buy
57,934
+8,859
+18% +$318K ﹤0.01% 1794
2021
Q1
$1.41M Sell
49,075
-3,095
-6% -$106K ﹤0.01% 1914
2020
Q4
$1.38M Buy
52,170
+6,678
+15% +$136K ﹤0.01% 1836
2020
Q3
$694K Sell
45,492
-6,569
-13% -$138K ﹤0.01% 1985
2020
Q2
$1.06M Sell
52,061
-1,031
-2% -$18.5K ﹤0.01% 1777
2020
Q1
$549K Sell
53,092
-1,833
-3% -$51.3K ﹤0.01% 1943
2019
Q4
$2.07M Buy
54,925
+5,900
+12% +$265K ﹤0.01% 1593
2019
Q3
$2.29M Buy
49,025
+5,900
+14% +$274K ﹤0.01% 1556
2019
Q2
$2.25M Buy
43,125
+4,543
+12% +$266K ﹤0.01% 1530
2019
Q1
$2.66M Sell
38,582
-4,376
-10% -$293K ﹤0.01% 1389
2018
Q4
$2.56M Sell
42,958
-3,586
-8% -$309K ﹤0.01% 1327
2018
Q3
$5.39M Sell
46,544
-30,543
-40% -$3.45M ﹤0.01% 1124
2018
Q2
$9.73M Buy
77,087
+10,212
+15% +$1.24M 0.01% 956
2018
Q1
$7.24M Buy
66,875
+9,196
+16% +$1.02M 0.01% 1016
2017
Q4
$6.32M Sell
57,679
-80,586
-58% -$8.04M 0.01% 1035
2017
Q3
$13.6M Buy
138,265
+148
+0.1% +$14.3K 0.01% 827
2017
Q2
$14M Buy
138,117
+6,504
+5% +$701K 0.01% 835
2017
Q1
$15.2M Buy
131,613
+16,882
+15% +$1.96M 0.02% 796
2016
Q4
$13.8M Buy
114,731
+556
+0.5% +$61.6K 0.02% 793
2016
Q3
$12.8M Buy
114,175
+626
+0.6% +$72.1K 0.01% 822
2016
Q2
$14.1M Buy
113,549
+8,283
+8% +$1,000K 0.02% 800
2016
Q1
$11.8M Buy
105,266
+61
+0.1% +$6.34K 0.01% 806
2015
Q4
$11.4M Sell
105,205
-5,241
-5% -$600K 0.01% 830
2015
Q3
$11M Sell
110,446
-1,809
-2% -$197K 0.01% 847
2015
Q2
$12.8M Sell
112,255
-7,214
-6% -$875K 0.01% 821
2015
Q1
$12.5M Sell
119,469
-1,762
-1% -$188K 0.01% 820
2014
Q4
$14.6M Sell
121,231
-2,597
-2% -$341K 0.01% 776
2014
Q3
$18.1M Buy
123,828
+482
+0.4% +$74.4K 0.02% 712
2014
Q2
$20.6M Buy
123,346
+10,390
+9% +$1.85M 0.02% 669
2014
Q1
$22.4M Buy
112,956
+13,770
+14% +$2.6M 0.02% 636
2013
Q4
$18.9M Buy
99,186
+4,030
+4% +$750K 0.02% 655
2013
Q3
$16.1M Buy
95,156
+4,847
+5% +$752K 0.02% 671
2013
Q2
$13.7M Buy
+90,309
New +$12.8M 0.02% 682

Other funds holding CLB